Recently, Li et al. 42 also demonstrated that SOX17 restrains proliferation and tumour formation in squamous cervical cancer by down‐regulating the activity of the Wnt–β‐catenin signalling pathway via trans‐suppression of β‐catenin. The gene discussed is SOX17; the disease is cervical squamous cell carcinoma.